A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.

Kotaro Kuwaki ¹, Keiichi Mitsuyama ², Hayato Kaida ³, Hidetoshi Takedatsu ¹, Shinichiro Yoshioka ¹, Hiroshi Yamasaki ¹, Ryosuke Yamauchi ¹, Shuhei Fukunaga ¹, Toshi Abe ³, Osamu Tsuruta ¹, Takuji Torimura ¹ , Cytotherapy. 2016 Feb;18(2):291-9.

The longitudinal changes in FDG-PET uptakes are of potential clinical interest for assessing the regional and global bowel disease activity in CD patients undergoing GMA therapy.

https://pubmed.ncbi.nlm.nih.gov/26700210/